Search

Your search keyword '"L. Flet"' showing total 63 results

Search Constraints

Start Over You searched for: Author "L. Flet" Remove constraint Author: "L. Flet"
63 results on '"L. Flet"'

Search Results

1. Use of artesunate in the treatment of severe imported malaria in France: review of the effectiveness and real-life safety in two French university hospitals

2. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trialResearch in context

3. Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trialResearch in context

4. Perfecționismul în copilărie și adolescență : O perspectivă a psihologiei dezvoltării

5. Impact des gestes barrière sur les dermites des mains en milieu hospitalier durant la pandémie à SARS-CoV-2

6. 5PSQ-087 Severe malaria: 3 year review of intravenous artesunate use in a university hospital

7. Étude comparative médico-économique des approches par chimiothérapie versus nouvelles thérapies anticancéreuses dans le mélanome de stade IIIC/IV

8. 4CPS-139 The piramid study: patients treated by myeloma oral medication have a bad compliance

9. First experience of Nusinersen early access program in patients with spinal muscular atrophy type 1

10. Safety, tolerability and clinical efficacy of nusinersen in SMA type 1 older than 7 months: a prospective study

11. First experience of Nusinersen early access program in patients with spinal muscular atrophy type 1

12. Safety, tolerability and clinical efficacy of nusinersen in SMA type 1 older than 7 months: a prospective study

14. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial

16. OP052 EFFECTS OF ORAL CITRULLINE ON WHOLE BODY PROTEIN METABOLISM IN HEALTHY HUMAN VOLUNTEERS: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY

17. O45 Le GFT505, un co-agoniste PPARα/δ, améliore la sensibilité périphérique et hépatique à l’insuline chez des patients obèses insulinorésistants

19. X-ray scattering measurements of dissociation-induced metallization of dynamically compressed deuterium

20. Physical activity of children from a small rural town, South Africa

21. Effect of alirocumab on postprandial hyperlipidaemia in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, cross-over trial.

22. Long-Term Clinical and Biological Prognostic Factors of Anti-NMDA Receptor Encephalitis in Children.

23. Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial.

24. PCSK9 inhibition protects mice from food allergy.

25. Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study.

26. Long-term outcome of paediatric anti-N-methyl-D-aspartate receptor encephalitis.

27. Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial.

28. Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.

29. Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children.

30. PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy.

31. Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol.

32. Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.

33. Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury: The COBI Randomized Clinical Trial.

34. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial.

35. Effect of High-Dose Baclofen on Agitation-Related Events Among Patients With Unhealthy Alcohol Use Receiving Mechanical Ventilation: A Randomized Clinical Trial.

36. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.

37. E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.

38. Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ 1 -HDL, α-HDL, and triglyceride-rich lipoproteins.

40. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.

41. Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.

42. VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.

43. Effect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over study.

44. What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France.

45. In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction.

46. Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.

47. Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.

48. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.

49. Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole.

50. Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.

Catalog

Books, media, physical & digital resources